NCT00808964View on ClinicalTrials.gov

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

September 30, 2013

Conditions
Heart Disease
Interventions
DRUG

NU172

NU172 administered IV bolus followed by continuous infusion during CABG surgery

Sponsors
All Listed Sponsors
lead

ARCA Biopharma, Inc.

INDUSTRY